Health ❯ Healthcare ❯ Drug Development

FDA Regulations

Drug Availability Drug Shortages Animal Testing Alternatives Breakthrough Therapy Designation Efficacy Studies

ATyr’s Sarcoidosis Drug Fails Phase 3 Goal, Shares Plunge Over 80%

The company plans an FDA meeting to review nominal signals from the trial.